Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Henderson

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Current Diabetes Reports|March 20, 2003
Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agentsDavid C Henderson
Evidence-Based Mental Health|August 23, 2011
Antipsychotic treatment associated with higher risk of hyperglycaemia in older persons with diabetesDavid C Henderson
The Journal of Clinical Psychiatry|August 19, 2005
Schizophrenia and comorbid metabolic disordersDavid C Henderson
CNS Spectrums|April 9, 2008
Considerations for inpatient versus outpatient treatment with antipsychoticsDavid C Henderson
The Journal of Clinical Psychiatry|November 2, 2007
Weight gain with atypical antipsychotics: evidence and insightsDavid C Henderson
The Journal of Clinical Psychiatry|March 28, 2008
Managing weight gain and metabolic issues in patients treated with atypical antipsychoticsDavid C Henderson
CNS Drugs|February 5, 2002
Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?David C Henderson
Expert Opinion on Pharmacotherapy|August 2, 2008
Sibutramine: current status as an anti-obesity drug and its future perspectivesBikash Sharma, David C Henderson
Evidence-Based Mental Health|June 26, 2012
Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorderNeelam Thakurathi, David C Henderson
Molecular Biotechnology|January 25, 2012
CKC: isolation of nucleic acids from a diversity of plants using CTAB and silica columnsDavid C Henderson, John Hammond
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Current Diabetes Reports|March 20, 2003
Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agentsDavid C Henderson
Evidence-Based Mental Health|August 23, 2011
Antipsychotic treatment associated with higher risk of hyperglycaemia in older persons with diabetesDavid C Henderson
The Journal of Clinical Psychiatry|August 19, 2005
Schizophrenia and comorbid metabolic disordersDavid C Henderson
CNS Spectrums|April 9, 2008
Considerations for inpatient versus outpatient treatment with antipsychoticsDavid C Henderson
The Journal of Clinical Psychiatry|November 2, 2007
Weight gain with atypical antipsychotics: evidence and insightsDavid C Henderson
The Journal of Clinical Psychiatry|March 28, 2008
Managing weight gain and metabolic issues in patients treated with atypical antipsychoticsDavid C Henderson
CNS Drugs|February 5, 2002
Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?David C Henderson
Expert Opinion on Pharmacotherapy|August 2, 2008
Sibutramine: current status as an anti-obesity drug and its future perspectivesBikash Sharma, David C Henderson
Evidence-Based Mental Health|June 26, 2012
Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorderNeelam Thakurathi, David C Henderson
Molecular Biotechnology|January 25, 2012
CKC: isolation of nucleic acids from a diversity of plants using CTAB and silica columnsDavid C Henderson, John Hammond
Pageof 17